Many Indian drug companies putting profit over patients' health: Katherine Eban
Investigative journalist Katherine Eban's book turns the lens on Indian generic drug industry in details and talks about shocking flaws. She turned to India as 40% of the US generic drugs are manufactured in India. Regular, unaccounced inspection of generic drug companies is needed, says Eban in an exclusive interview with ETNOW.
Other Expert Views Videos
Smallcap investing: timing, risk, and returns | Golden Thumb Rule ft Aniruddha Naha
Market fall sparks buy call: Prateek Agrawal on why this dip may be an opportunity
The Golden Thumb Rule | Should you pause your SIP in a market fall? checklist inside
First in Motilal Oswal AMC investing series: QGLP principles for disciplined investing
Rebalance when asset weights drift, not when headlines shout: DSP CEO Kalpen Parekh